David E. Smith, MD

Affiliations: 
 
Google:
"David Smith"
Bio:

Galveston, TX 77551-1737
United States

Mean distance: 16.37 (cluster 6)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Grulich AE, Jin F, Bavinton BR, et al. (2021) Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study. The Lancet. Hiv
Sun X, Cremons DR, Mazarico E, et al. (2021) Small All-Range Lidar for Asteroid and Comet Core Missions. Sensors (Basel, Switzerland). 21
Moran M, Blum K, Ponce JV, et al. (2021) High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial. Molecular Neurobiology
Smith DE, Woolley IJ, Russell DB, et al. (2020) Trends in practice: attitudes and challenges in the diagnosis, treatment and management of HIV infection in Australia. Internal Medicine Journal. 50: 5-17
Blum K, Lott L, Baron D, et al. (2020) Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usual. Journal of Systems and Integrative Neuroscience. 7
Hu Y, Gruber KA, Smith DE. (2020) Characterization of the cellular transport mechanisms for the anti-cachexia candidate compound TCMCB07. Journal of Cachexia, Sarcopenia and Muscle
Thompson BR, Shi J, Zhu HJ, et al. (2020) Pharmacokinetics of Gemcitabine and its Amino Acid Ester Prodrug following Intravenous and Oral Administrations in Mice. Biochemical Pharmacology. 114127
Cremons DR, Sun X, Denny Z, et al. (2020) Optical characterization of laser retroreflector arrays for lunar landers. Applied Optics. 59: 5020-5031
Edwards D, Roy AK, Boyett B, et al. (2020) Addiction by Any Other Name is Still Addiction: Embracing Molecular Neurogenetic/Epigenetic Basis of Reward Deficiency. Journal of Addiction Science. 6: 1-4
Shenoy VM, Thompson BR, Shi J, et al. (2020) Chemoproteomic Identification of Serine Hydrolase RBBP9 as a Novel Valacyclovir-Activating Enzyme. Molecular Pharmaceutics
See more...